NCT06336772View on ClinicalTrials.gov

Restylane Shaype Versus Juvederm Volux for Chin Augmentation

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

October 9, 2024

Study Completion Date

November 9, 2024

Conditions
Chin Retrusion
Interventions
DEVICE

Restylane Shaype

Half (50%) of study participants will receive Restylane Shaype for the treatment of mild to severe chin retrusion

DEVICE

Juvéderm Volux

Half (50%) of study participants will receive Juvéderm Volux for the treatment of mild to severe chin retrusion

Trial Locations (1)

H3R3A1

Erevna Innovations Inc., Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER